-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Downgrades enGene Therapeutics to Underweight

Benzinga·06/18/2026 10:48:51
Listen to the news
Morgan Stanley analyst Judah Frommer downgrades enGene Therapeutics (NASDAQ:ENGN) from Equal-Weight to Underweight.